When will GSK pull plug on oncology

GSK won't pull the plug on the OBU. Rather, it will be run poorly and under perform. Typical business unit at GSK, poorly run and under performing.

 

We're elite. We don't under perform. Get it right, PC loser.

 

hmmm....are you talking about the same OBU as everyone else. Very few territories are doing anything well. Zejula is an okay drug but it’s not Going to do much more than it is. Blenrep patients are so beat up by the time they get treated they don’t stay on long. Hard to work with that if you are an honest rep.